imposition of fine
LOTUSEYE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 1.5 pts more than Nifty Microcap 250 and 0.8 pts more than its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Both BSE and NSE have imposed a fine of Rs 2,95,000 each (inclusive of GST) on Lotus Eye Hospital, totaling approximately Rs 5,90,000. The fine is for non-compliance of Regulation 17(1A) of SEBI LODR 2015, which typically pertains to board composition and director appointment rules (such as appointment of non-executive directors aged 75 or above). The action was communicated via email and letter dated 28th November 2025. The company has stated there is no material impact on its financial operations.
This is a relatively minor regulatory compliance penalty and the company has confirmed no material impact on financials or operations. Investors should monitor compliance with corporate governance norms, but the direct impact on stock price or shareholder value is likely negligible.